ANI Pharmaceuticals, Inc. Insider Transactions
ANI Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC. |
Sell | 250 @ $66.54 | $16,635 | 59,981 | 03/13/2024 | 03/13/2024 | |
|
Gassert Chad
SVP - CORP. DEV. & STRATEGY |
Sell | 20,000 @ $65.81 | $1.32 M | 273,226 | 03/11/2024 | 03/13/2024 | |
|
CAREY STEPHEN P.
SVP & CFO |
Sell | 7,787 @ $65.55 | $510,438 | 177,712 | 03/11/2024 | 03/11/2024 | |
|
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 10,000 @ $67.17 | $671,700 | 832,620 | 03/08/2024 | 03/11/2024 | |
|
Lalwani Nikhil
CEO |
Sell | 16,292 @ $67.13 | $1.09 M | 411,629 | 03/08/2024 | 03/08/2024 | |
|
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 15,085 @ $66.35 | $1.00 M | 842,620 | 03/07/2024 | 03/07/2024 | |
|
Marken James G.
SVP OPS & PROD DEV |
Sell | 24,338 @ $66.37 | $1.62 M | 124,492 | 03/07/2024 | 03/07/2024 | |
|
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 14,822 @ $65.47 | $970,396 | 857,705 | 03/06/2024 | 03/07/2024 | |
|
Lalwani Nikhil
CEO |
Sell | 28,965 @ $65.52 | $1.90 M | 444,981 | 03/06/2024 | 03/08/2024 | |
|
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 10,093 @ $65.35 | $659,578 | 872,527 | 03/05/2024 | 03/07/2024 | |
|
Mutz Christopher
HEAD OF RARE DISEASE |
Sell | 5,000 @ $66.00 | $330,000 | 87,387 | 03/05/2024 | 03/06/2024 | |
|
Pera Antonio R
Director |
Sell | 7,000 @ $65.20 | $456,400 | 26,627 | 03/04/2024 | 03/06/2024 | |
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC. |
Sell | 250 @ $56.04 | $14,010 | 36,799 | 02/13/2024 | 02/13/2024 | |
|
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 15,000 @ $56.44 | $846,600 | 882,620 | 01/23/2024 | 01/23/2024 | |
|
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 5,692 @ $55.95 | $318,467 | 897,620 | 01/22/2024 | 01/23/2024 | |
|
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 4,524 @ $55.57 | $251,399 | 903,312 | 01/19/2024 | 01/23/2024 | |
|
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 9,784 @ $55.30 | $541,055 | 907,836 | 01/18/2024 | 01/18/2024 | |
|
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 10,000 @ $55.11 | $551,100 | 917,620 | 01/17/2024 | 01/18/2024 | |
|
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 5,000 @ $55.63 | $278,150 | 927,620 | 01/16/2024 | 01/18/2024 | |
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC. |
Sell | 250 @ $56.43 | $14,108 | 37,049 | 01/12/2024 | 01/16/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ANI Pharmaceuticals, Inc. FAQ's
The list of insiders at ANI Pharmaceuticals, Inc. includes Gassert Chad, Cook Meredith, Shanmugam Muthusamy, Lalwani Nikhil, TANNENBAUM RENEE P, Mutz Christopher, CAREY STEPHEN P., Gutwerg Ori, Davis Krista.
Insiders have sold a total of 359,385 ANI Pharmaceuticals, Inc. shares in the last 12 months for a total of 22.68 M sold.
The following insiders have sold ANI Pharmaceuticals, Inc. shares in the last 12 months: Gassert Chad ($5.23 M), Cook Meredith ($138,855), Shanmugam Muthusamy ($12.64 M), Lalwani Nikhil ($3.04 M), TANNENBAUM RENEE P ($127,740), Mutz Christopher ($498,270), CAREY STEPHEN P. ($736,325), Gutwerg Ori ($199,995), Davis Krista ($60,000),